An anecdotal case with a de novo SCN2A splice site mutation associated with epileptic encephalopathy, early onset global developmental delay, intermittent ataxia, autism, hypotonia, and cerebral/cerebellar atrophy was recently reported. The gene discussed is SCN2A; the disease is Epileptic encephalopathy.